Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Trump says Iran deal coming Sunday

June 13, 2026

FemiCore [Exclusive Report 2026] Femi Core Warning Why Thousands of Women Are Suddenly Talking About This Bladder Health Supplement

June 13, 2026

Deadly Ontario collision leaves 10 injured or killed: OPP

June 13, 2026

Apple’s new AI photo editing tools mostly work, for better and worse

June 13, 2026

Critics say Canada’s new immigration and border law puts LGBTQ+ people in danger

June 13, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
Press Release

Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies

By News RoomJanuary 5, 20242 Mins Read
Global Menopausal Hot Flashes Market: Growth in Non-Hormonal Treatments and use of Online Pharmacies
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Jan. 05, 2024 (GLOBE NEWSWIRE) — The “Global Menopausal Hot Flashes Market by Treatment Type (Alternative Treatment, Hormonal Treatment, Non-Hormonal Treatment), Distribution Channel (Hospital Pharmacies, Online Pharmacies, Retail Pharmacies) – Forecast 2023-2030” report has been added to ResearchAndMarkets.com’s offering.

The Menopausal Hot Flashes Market size was estimated at USD 7.83 billion in 2022, USD 8.24 billion in 2023, growing at a CAGR of 6.06% to reach USD 12.54 billion by 2030.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Menopausal Hot Flashes Market.

  • Based on Treatment Type, the market is studied across Alternative Treatment, Hormonal Treatment, and Non-Hormonal Treatment. The Alternative Treatment is is further studied across Black Cohosh, Herbal Medicines, and Vitamin E. The Hormonal Treatment is is further studied across Estrogen, Estrogen-Progesterone Combination, and Progesterone. The Non-Hormonal Treatment is projected to witness significant market share during forecast period.
  • Based on Distribution Channel, the market is studied across Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies. The Online Pharmacies is projected to witness significant market share during forecast period.
  • Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. Key Attributes:
Report Attribute Details
No. of Pages 197
Forecast Period 2023 – 2030
Estimated Market Value (USD) in 2023 $8.24 Billion
Forecasted Market Value (USD) by 2030 $12.54 Billion
Compound Annual Growth Rate 6.0%
Regions Covered Global

Companies Mentioned

  • A.Vogel Ltd.
  • Apotex Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Fervent Pharmaceuticals, LLC
  • Glenmark Pharmaceuticals Ltd.
  • Mithra Pharmaceuticals
  • Novartis AG
  • Pfizer Inc.
  • Teva Pharmaceuticals Ltd.
  • TherapeuticsMD, Inc.
  • Zywie Ventures Private Limited

For more information about this report visit https://www.researchandmarkets.com/r/9wmabe

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

  • Global Menopausal Hot Flashes Market

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

FemiCore [Exclusive Report 2026] Femi Core Warning Why Thousands of Women Are Suddenly Talking About This Bladder Health Supplement

INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Zscaler

BTGO EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds BitGo Holdings (BTGO) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

FemiCore (Official Website & Authenticity Notice 2026) – Counterfeit Risks and What Consumers Should Know

BMI EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Badger Meter (BMI) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026

Hyderabad Sees Surge in Dining Table Rentals in 2026 as Salaried IT Professionals Reject ₹45,000 EMI Lock-Ins for ₹1,400/Month Plans From Rentomojo

PHR EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Phreesia (PHR) Investors of Securities Class Action Lawsuit Deadline on July 13, 2026

RBLX EQUITY ACTION REMINDER: Faruqi & Faruqi, LLP Notifies Roblox (RBLX) Investors of Securities Class Action Lawsuit Deadline on August 7, 2026

Don’t Pay Full Price for Power: WattCycle’s Prime Day Event Drops Up to 70% Off LiFePO4 Batteries Starting June 15

Editors Picks

FemiCore [Exclusive Report 2026] Femi Core Warning Why Thousands of Women Are Suddenly Talking About This Bladder Health Supplement

June 13, 2026

Deadly Ontario collision leaves 10 injured or killed: OPP

June 13, 2026

Apple’s new AI photo editing tools mostly work, for better and worse

June 13, 2026

Critics say Canada’s new immigration and border law puts LGBTQ+ people in danger

June 13, 2026

Latest News

Microsoft hasn’t ruled out spinning off Xbox

June 13, 2026

Bose’s latest QuietComfort Ultra are $70 off, marking a new low price 

June 13, 2026

My first 24 hours with Siri AI on the Mac

June 13, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version